Antitussive effects of the H1-receptor antagonist epinastine in patients with atopic cough (Eosinophilic bronchitis)

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 4, 2004, Pages 207-212

  Shioya, Takanobu ^a   Satake, Masahiro ^a   Kagaya, Manabu ^a   Sano, Masa Aki ^a   Watanabe, Akiko ^a   Fukui, Shin ^a   Sasaki, Masahiro ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Alesion , antitussive effects, clinical studies; Atopic cough; CAS 80012 43 7; Eosinophilic bronchitis; Epinastine hydrochloride; Histamine H 1 receptor antagonist

Indexed keywords

ANTITUSSIVE AGENT; CAPSAICIN; CAS 80012437; EPINASTINE; HISTAMINE H1 RECEPTOR ANTAGONIST; METHACHOLINE; PLACEBO; DIAGNOSTIC AGENT; DIBENZAZEPINE DERIVATIVE; IMIDAZOLE DERIVATIVE; METHACHOLINE CHLORIDE; MUSCARINIC AGENT;

ADULT; AGED; ARTICLE; ATOPY; BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; EOSINOPHILIC BRONCHITIS; EXPIRATORY FLOW RATE; FEMALE; HUMAN; LUNG FUNCTION; MALE; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; BRONCHUS HYPERREACTIVITY; CHEMICALLY INDUCED DISORDER; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ANTITUSSIVE AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHITIS; CAPSAICIN; COUGH; DIBENZAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; IMIDAZOLES; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; MUSCARINIC AGONISTS; RESPIRATORY FUNCTION TESTS;

EID: 1942532016     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296961     Document Type: Article

References (25)

1. Irwin, R. S, Boulet, L.-P., Cloutier, M. M. et al., Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 114, 133S (1998)
2. Corrao, W. M., Braman, S. S., Irwin, R. S. et al., Chronic cough as the sole presenting manifestation of bronchial asthma. N. Engl. J. Med. 300, 633 (1979)
3. Gibson, P. G., Dolovich, J., Denburg, J. et al., Chronic cough: eosinophilic bronchitis without asthma. Lancet 11, 1346 (1989)
4. Fujimura, M., Ogawa, H., Yasui, M. et al., Eosinophilic tracheobronchitis and airway cough hypersensitivity in chronic non-productive cough. Clin. Exp. Allergy 30, 41 (2000)
5. Brightling, C. E., Ward, R., Wardlaw, R. et al., Pavord, ID. Airway inflammation, airway responsiveness and cough before and inhaled budesonide in patients with eosinophiic bronchitis. Eur. Respir. J. 15, 682 (2000)
6. Gibson, P. G., Fujimura, M., Niimi, A., Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax 57, 178 (2002)
7. Jackson, W. R., Cop, F. C., Cullen, J. D. et al., Chemical Design of peripherally acting compounds. Clin. Exp. Pharmacol. Physiol. 19, 17 (1992)
8. Tasaka, K., Kamei, C., Nakamura, S., Inhibitory effect of epinastine (WAL 801 CL) on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats. Arzneim.-Forsch./Drug Res. 44 (I), 327 (1994)
9. Definition of atopic cough: Japanese Cough Research Association, Proceedings Tokyo Conference, Tokyo, June 2001
10. Takishima, T., Hida, W., Sasaki, H. et al., Direct-writing recorder of the dose-response curves of the airway to methacholine, Clinical application. Chest 80, 600 (1981)
11. Midgren, B., Hansson, L., Karlsson, J.-A. et al., Simonsson BG, Pensson CGA. Capsaicin-induced cough in humans. Am. Rev. Respir. Dis. 146, 347 (1992)
12. Shioya, T., Ito, N., Sasaki, M. et al., Cough threshold for capsaicin increases by azelastine in patients with cough-variant asthma. Pulm. Pharmacol. 9, 59 (1996)
13. Shioya, T., Ito, N., Watanabe, A. et al., Antitussive effect of azelastine hydrochloride in patients with bronchial asthma. Arzneim.-Forsch./ Drug Res. 48 (I), 149 (1998)
14. Widdicombe, J. G., Neurophysiology of the cough reflex. Eur. Respir. J. 8, 1193 (1995)
15. Ravi, K., Teo, K., Kappagoda, C. T., Action of histamine on the rapidly adapting stretch receptors in the dog. Can. J. Physiol. Pharmacol. 67, 1499 (1989)
16. Eyre, P., Chand, N., Histamine receptor mechanism of the lung. In: Pharmacology of histamine receptors, C. R. Ganellin, M. E. Parsons (eds.), pp. 298-322, The Stonebridge Press, Bristol (1982)
17. Fox, A. J., Modulation of cough and airway sensory fibers. Pulm. Pharmcol. 9, 335 (1996)
18. Schmelz, M., Schmidt, R., Bickel, A. et al., Specific c-receptors for itch in human skins. J. Neurosci. 17, 8003 (1997)
19. Kemei, J., Norita, M., Ohsawa, M. et al., Effects of epinastine on the antitussive and rewarding effects of dihydrocodeine in mice. Methods Find. Exp. Clin. Pharmacol. 21, 663 (1999)
20. Ito, N., Shioya, T., Watanabe, A. et al., Mechanism of the antitussive effect of azelstine in guinea pigs. Arzneim.-Forsch./ Drug Res. 52 (I), 441 (2002)
21. Dupon, L. J., Maede, C. J., Demedis, M. G. et al., Epinastine modulates the noncholinergic contraction in guinea-pig airways in vitro by a prejunctional 5-HT1-like receptor. Eur. Respir. J. 9, 1433 (1996)
22. Dupon, L. J., Pype, J. L., Maede, C. J. et al., Epinastine (WAL 801CL) inhibits the electrical field stimulation-induced cholinergic contraction in guinea pig and human airways in vitro. Eur. Respir. J. 14, 1068 (1999)
23. Stone, R. A., Barnes, P. J., Chung, K. F., Effect of 5-HT1A receptor agonist, 8-OH-DPAT, on cough responses in the conscious guinea pig. Eur. J. Pharmacol. 332, 201 (1997)
24. O'Connell, F., Central pathways for cough in man-unanswered questions. Pulm. Pharmacol. Ther. 15, 295 (2002)
25. Yanai, K., Ryu, J. H., Watanabe, T. et al., Iwata, R, Ido, T, Asakura, M, Matsumura, R, Itoh, M. Positron emission tomographic study of central histamine H1-receptor occupancy in human subjects treated with epinastine, a second-generation antihistamine. Methods Find. Exp. Clin. Pharmacol. 17, 64 (1995)